92 related articles for article (PubMed ID: 6193344)
1. CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers.
Jacot des Combes B; Turini GA; Brunner HR; Porchet M; Chen DS; Sen S
J Cardiovasc Pharmacol; 1983; 5(4):511-6. PubMed ID: 6193344
[TBL] [Abstract][Full Text] [Related]
2. A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers.
Schaller MD; Brunner DB; Nussberger J; Turini GA; Sen SB; Chen D; Waeber B; Brunner HR
Eur J Clin Pharmacol; 1984; 26(4):419-24. PubMed ID: 6329767
[TBL] [Abstract][Full Text] [Related]
3. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
4. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
[TBL] [Abstract][Full Text] [Related]
5. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
[TBL] [Abstract][Full Text] [Related]
6. Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers.
Schaller MD; Nussberger J; Waeber B; Bussien JP; Turini GA; Brunner H; Brunner HR
Eur J Clin Pharmacol; 1985; 28(3):267-72. PubMed ID: 2988972
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
[TBL] [Abstract][Full Text] [Related]
8. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
[TBL] [Abstract][Full Text] [Related]
10. The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteers.
Bussien JP; Nussberger J; Porchet M; Waeber B; Brunner HR; Perisic M; Tansey MJ; Bomm M; Hajdu P
Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):63-9. PubMed ID: 2987705
[TBL] [Abstract][Full Text] [Related]
11. RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.
Burnier M; Turini GA; Brunner HR; Porchet M; Kruithof D; Vukovich RA; Gavras H
Br J Clin Pharmacol; 1981 Dec; 12(6):893-9. PubMed ID: 6280740
[TBL] [Abstract][Full Text] [Related]
12. [Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship].
Richer C; Thuillez C; Desmichels D; Giudicelli JF
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):913-8. PubMed ID: 3026273
[TBL] [Abstract][Full Text] [Related]
13. Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.
Richer C; Thuillez C; Giudicelli JF
J Cardiovasc Pharmacol; 1987 Jan; 9(1):94-102. PubMed ID: 2434802
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.
Chatelain RE; Ghai RD; Trapani AJ; Odorico LM; Dardik BN; De Lombaert S; Lappe RW; Fink CA
J Pharmacol Exp Ther; 1998 Mar; 284(3):974-82. PubMed ID: 9495857
[TBL] [Abstract][Full Text] [Related]
15. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
Nussberger J; Brunner DB; Waeber B; Brunner HR
J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
18. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
19. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
[TBL] [Abstract][Full Text] [Related]
20. Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects.
Bussien JP; d'Amore TF; Perret L; Porchet M; Nussberger J; Waeber B; Brunner HR
Clin Pharmacol Ther; 1986 May; 39(5):554-8. PubMed ID: 3516512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
